| 1 (34) | DeepMind Technologies Ltd, UK | GBR |  |  |
| 2 (160) | IBM Switzerland | CHE | | |
| 3 (169) | Ericsson Sweden | SWE | | |
| 4 (194) | Microsoft, United Kingdom | GBR | | |
| 5 (223) | Microsoft Research Cambridge, UK | GBR | | |
| 6 (241) | Huawei Technologies Ltd, Germany | DEU | | |
| 7 (259) | Novartis Institutes for Biomedical Research, Switzerland | CHE | | |
| 8 (279) | Banco Bilbao Vizcaya Argentaria, Spain | ESP | | |
| 9 (296) | Hoffmann-La Roche, GmbH., Germany | DEU | | |
| 10 (323) | AstraZeneca, United Kingdom | GBR | | |
| 11 (369) | Orange SA, France | FRA | | |
| 12 (387) | Nordic Bioscience A/S | DNK | | |
| 13 (396) | Sanofi, France | FRA | | |
| 14 (403) | UCB Pharma SA, UK | GBR | | |
| 15 (418) | Nokia, France | FRA | | |
| 16 (433) | Bayer AG, Germany | DEU | | |
| 17 (436) | Philips Research, Eindhoven | NLD | | |
| 18 (465) | Nokia Bell Labs, France | FRA | | |
| 19 (466) | Novo Nordisk A/S | DNK | | |
| 20 (491) | AstraZeneca, Sweden | SWE | | |
| 21 (493) | Frontiers Media SA | CHE | | |
| 22 (499) | Nestle Switzerland | CHE | | |
| 23 (520) | Siemens AG, Germany | DEU | | |
| 24 (526) | Janssen Research & Development, LLC | BEL | | |
| 25 (556) | Bosch, Germany | DEU | | |
| 26 (579) | CaixaBank SA * | ESP | | |
| 27 (582) | Deutsche Telekom AG, Germany | DEU | | |
| 28 (589) | GlaxoSmithKline, United Kingdom | GBR | | |
| 29 (605) | BMW AG, Germany | DEU | | |
| 30 (642) | Merck KGaA, Germany | DEU | | |
| 31 (656) | Hoffmann-La Roche Ltd, Switzerland | CHE | | |
| 32 (739) | Siemens Healthineers, Germany | DEU | | |
| 33 (760) | GlaxoSmithKline, Belgium | BEL | | |
| 34 (761) | BASF, Germany | DEU | | |
| 35 (794) | IMEC International * | BEL | | |
| 36 (812) | Sanofi, Germany | DEU | | |
| 37 (874) | Carl Zeiss AG | DEU | | |
| 38 (920) | UCB Pharma SA, Belgium | BEL | | |
| 39 (958) | Infineon Technologies Austria AG | AUT | | |
| 40 (963) | Novartis, Switzerland | CHE | | |
| 41 (1022) | Volkswagen AG, Germany | DEU | | |
| 42 (1068) | Boehringer Ingelheim GmbH Germany | DEU | | |
| 43 (1131) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | | |
| 44 (1217) | BASF, Spain | ESP | | |
| 44 (1217) | Syngenta, United Kingdom | GBR | | |
| 46 (1234) | Pfizer Inc, Spain | ESP | | |
| 47 (1312) | Thales Group France SA | FRA | | |
| 48 (1334) | Repsol, Spain | ESP | | |
| 49 (1400) | BMJ Group | GBR | | |
| 50 (1416) | Telefonica SA, Spain | ESP | | |
| 51 (1771) | Infineon Technologies Germany | DEU | | |
| 52 (1785) | Unilever, United Kingdom | GBR | | |
| 53 (1790) | Pfizer Inc, United Kingdom | GBR | | |
| 54 (1935) | STMicroelectronics, Italy | ITA | | |
| 55 (2010) | Shell, Netherlands | NLD | | |
| 56 (2240) | Endesa SA, Spain | ESP | |  |
| 57 (2379) | SINTEF Group * | NOR | | |
| 58 (2685) | STMicroelectronics, France | FRA | | |
| 59 (2790) | Naturgy Energy Group SA, Spain | ESP | | |
| 60 (2910) | Enel Iberia SL, Spain | ESP | | |
| 61 (2938) | Thales Alenia Space, France | FRA | | |
| 62 (3004) | TotalEnergies, France | FRA | | |
| 63 (3016) | Airbus, France | FRA | | |
| 64 (3093) | Airbus, Germany | DEU | | |
| 65 (3185) | Electricite de France, S.A. * | FRA | | |
| 66 (3282) | Rolls-Royce plc, United Kingdom | GBR | | |
| 67 (3319) | European XFEL GmbH | DEU | | |
| 68 (3450) | EDP Espana * | ESP | | |
| 69 (3607) | Empresa Nacional del Gas SA * | ESP | | |
| 70 (3993) | Construcciones y Auxiliar de Ferrocarriles SA * | ESP | | |
| 71 (4873) | Eni, SpA | ITA | | |
| 72 (5404) | Equinor ASA, Norway | NOR | | |
| 73 (5712) | Grupo Jose de Mello * | PRT | | |
| 74 (5931) | Ensino Lusofona * | PRT | | |
| 75 (6040) | Elettra Sincrotrone Trieste | ITA | | |
| 76 (6046) | Siemens Energy, Germany | DEU | | |
| 77 (7224) | ARUP | GBR | |  |
| 78 (8290) | Baker Hughes, Italy | ITA | | |
|
